The binding of CXCL8 to its receptors CXCR1 and CXCR2 leads to the activation and downstream trafficking of inflammatory mediators, tumor proliferation and breast cancer development (Mishra et al., 2021). The gene discussed is CXCL8; the disease is breast cancer.